EMA's PRAC Initiates Safety Review of Injectable Iron-Containing Medicines

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has commenced a safety review of injectable iron-containing medicines. This regulatory action indicates a re-evaluation of the safety profile of these products, which could lead to updated guidance or restrictions to ensure patient safety within the European Union.